Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

E. Merck continues to investigate angiotensin II blockers

May 10, 1996

Daicel reports neuronal cell protectant

May 10, 1996

Bayer reports K+ channel modulators for CNS disorders

May 10, 1996

5-HT reuptake inhibitors reported by HMR

May 10, 1996

Taisho discloses new series of sigma-receptor ligands

May 10, 1996

Santen reports sigma receptor ligands as potential psychopharmacologic drugs

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Hoechst claims bile acid sequestrants

May 10, 1996

Corydalin: ACAT inhibitor from natural source

May 10, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 22, 2025.
Makary’s vision for slimmed-down US FDA somewhat reassuring
BioWorld
Nearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s...
Roche follows other pharmas, committing $50B in US investment
BioWorld
Roche AG has become the latest pharmaceutical company to respond to the Trump administration’s threat to impose tariffs, saying it will invest $50 billion in drug...
Dupixent bounces back in treating hives with FDA approval
BioWorld
The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for...